1-9 of 9
Per Morten Sandset, MD PhD
Close
Sort by
Journal Articles

Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions

Charles T Nakar, MD, Joseph M Parker, MD, Neelam Thakral, Brandon M. Hardesty, MD, Gary Albert, Pierre Laurin, MSc, BPharm, John Moran, MD, Per Morten Sandset, MD PhD, Amy D. Shapiro, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 84.
https://doi.org/10.1182/blood.V130.Suppl_1.84.84
Published: 2017
Journal Articles

Improved Functional Outcome After Additional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Results of a Randomized Controlled Clinical Trial (The CaVenT Study)

Tone Rønnaug Enden, MD, PhD, Ylva Haig, MD, Nils-Einar Kløw, MD, PhD, Carl Erik Slagsvold, MD, PhD, Leiv Sandvik, PhD, Waleed Ghanima, MD, PhD, Geir Hafsahl, MD, PhD, Pål Andre Holme, MD, PhD, Lars Olaf Holmen, MD, Anne Mette Njaastad, MD, Gunnar Sandbaek, MD, PhD, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2011) 118 (21): LBA-1.
https://doi.org/10.1182/blood.V118.21.LBA-1.LBA-1
Published: 2011
Journal Articles

Candidate Gene Polymorphisms and the Risk for Pregnancy Related Venous Thrombosis

Anders E. A. Dahm, PhD, Irene D. Bezemer, PhD, Astrid Bergrem, PhD, Anne Flem Jacobsen, PhD, Eva Marie Jacobsen, PhD, Grethe Skretting, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4203.
https://doi.org/10.1182/blood.V116.21.4203.4203
Published: 2010
Journal Articles

Adjunctive Catheter-Directed Venous Thrombolysis in Iliofemoral Deep Vein Thrombosis; Short-Term Results from the CaVenT Study, a Multicenter Randomized Controlled Trial

Tone Rønnaug Enden, MD, Carl-Erik Slagsvold, MD, PhD, Nils-Einar Kløw, MD, PhD, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 989.
https://doi.org/10.1182/blood.V112.11.989.989
Published: 2008
Journal Articles

Increased Bone Marrow Microvascular Density in Hematologic Malignancies

Helene Francisca Stigter Negaard, MD, Nina Iversen, PhD, Inger Marie Bowitz-Lothe, MD, Per Morten Sandset, MD, PhD, Brit Steinsvik, Bjørn Østenstad, MD, PhD, Per Ole Iversen, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5456.
https://doi.org/10.1182/blood.V112.11.5456.5456
Published: 2008
Journal Articles

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Anders E.A. Dahm, MD, Nina Iversen, PhD, Baard Birkenes, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3961.
https://doi.org/10.1182/blood.V106.11.3961.3961
Published: 2005
Journal Articles

A Novel Assay for Tissue Factor Pathway Inhibitor (TFPI) Anticoagulant Activity in Plasma.

Anders E.A. Dahm, MD, Trine O. Andersen, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3987.
https://doi.org/10.1182/blood.V104.11.3987.3987
Published: 2004
Journal Articles

Biological Relevance of a New TFPI Anticoagulant Activity Assay of Full-Length TFPI.

Anders E.A. Dahm, MD, Trine O. Andersen, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2982.
https://doi.org/10.1182/blood.V104.11.2982.2982
Published: 2004
Journal Articles

A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients.

Waleed Ghanima, MD, Vibeke Almaas, MD, Saad Aballi, MD, Dorje Christina, MD, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1766.
https://doi.org/10.1182/blood.V104.11.1766.1766
Published: 2004